Skip to Content

Keith F. Fournier, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2000 Dartmouth Medical School, Hanover, NH, MD, Doctor of Medicine
1993 University of New England, Biddeford, ME, BS, Summa Cum Laude, Medical Biology


Institutional Committee Activities

Co-Chair, Gastric Cancer Conference, 5/2011-present
Member, Clinical Effectiveness Subcommittee, 2011-present
Member Alternate - Surgical Oncology, Credentials Committee of the Medical Staff, 2011-present
Member, Institutional Review Board 1, 10/2010-present
Member, Faculty Senate, 10/2010-present
Member, Medical Student Education Committee, 7/2010-present
Co-Chair, Peritoneal Cancer Conference, 6/2010-present
Member/Mento, Fellows Education Committee, 2010-present
Member, Surgical Oncology Fellow Education Committee, 10/2009-present
Member, Resident Education Committee, 9/2009-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Hsu C, Rashid A, Xing Y, Chiang YJ, Chagpar RB, Fournier KF, Chang GJ, You YN, Feig BW, Cormier JN. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype". J Surg Oncol 107(2):136-43, 2/2013. e-Pub 7/5/2012. PMID: 22767417.
2. Lieu CH, Lambert LA, Wolff RA, Eng C, Zhang N, Wen S, Rafeeq S, Taggart M, Fournier K, Royal R, Mansfield P, Overman MJ. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol 23(3):652-8, 3/2012. e-Pub 6/8/2011. PMCID: PMC3331734.
3. Bartley AN, Rashid A, Fournier KF, Abraham SC. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: Evidence for a common cell of origin in composite tumors. Hum Pathol 42(10):1420-9, 10/2011. e-Pub 3/2011. PMID: 21419473.
4. Raghav KP, Taggart MW, Fournier KF, Overman MJ. Is malignant dedifferentiation for mucinous appendiceal neoplasms a valid phenomenon or merely histopathologic ambiguity? J Am Coll Surg 212(5):212(5):906, 5/2011. PMID: 21530846.
5. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ, Choi W. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 69(14):5820-8, 7/2009. e-Pub 7/2009. PMID: 19584296.
6. Shin S, Fournier K, Cole C, Laronga C. Effect of Sentinel Lymph Node Biopsy on surgical residency training. American Surgeon(72 9):791-795, 9/2006. PMID: 16966388.
7. Yang H, Zhang Y, Zhao R, Fournier K, Wu HB, Yang HY, Diaz J, Laronga C, Lee MH. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip 1 by inhibiting the activity of PKB/Akt. Oncogene. Oncogene(25 33):4585-94, 8/2006.
8. Fournier K, Schiller A, Perry RR, Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary node dissection. Annals of Surgery(859-63):859-63; discussion 863-5, 6/2004. PMID: 15166965.

Last updated: 8/11/2015